Bibliografía
 

2. Murphy JG, Steckelberg JM. New developments in infective endocarditis. Curr Opin Cardiol 1995; 10 (2):150-154.

3. Terpenning M, Buggy B, Kauffman C. Infective endocarditis: Clinical features in young and elderly pantients. Am J Med 1987; 83:626.

4. Weinberger I, Rotenberg Z, Zacharovitch D, et al. Native valve infective endocarditis in the 1970´s versus 1980´s: Underlying cardiac lesions and infecting organisms. Clin Cardiol 1990; 13:94.

5. Lacassin F, Leport C. Infectious endocarditis, risk factors, prevention. Research group for infectious endocarditis and jury of the consensus conference. Rev Med Interne. 1993; 14(9):871-876.

6. Hogevik H, Olaison l, Andersson R, Lindberg J, Alestig K. Epidemiologic aspects of infective endocarditis in an urban population. A 5-years prospective study. Medicine (Baltimore) 1995; 74:324-339.

7. Miró JM, Forcades T, Pérez Villa F. Tratamiento y profilaxis de la endocarditis infecciosa. Inf Ter Sist Nac Salud 1991; 15: 193-208.

8. Kaye D. Definitions and demographic characteristics. In: Kaye D. (Ed.): Infective endocarditis. Baltimore, University Park Press 1976; 1-10.

9. Von Reyn CF, Levy BS, Arbeit, Friedland G, Crumpacker CS. Infective endocarditis: an analysis based on strict case definitions. Ann Intern Med 1981; 94:505-518.

10. Scheld Wm, Sande MA. Endocarditis and intravascular infections. In: Manell Gl et al (eds): Infectious Diseases, 4th edition. New York, ChurChill Livingstone Inc. 1995, 740-773. 

11. Pelletier LL Jr, Petersdorf RG. Infective endocarditis: A review of 125 cases from the University of Washington Hospitals 1963-72. Medicine 1977; 56:287.

12. Garvey GJ, Neu HC. Infectivve endocarditis -an evolving disease. A review of endocarditis at the Columbia-Presbyterian Medical Centre 1968-1973. Medicine 1978; 57:105.

13. Sharma S, Desai AG, Pillai MG, et al. Clinical and diagnostic features of pulmonary valve endocarditis in the setting of congenital cardiac malformations. Int. J. Cardiol. 1985; 9:457.

14. McKinsey DS, Ratts TE, Bisno AL. Underlying cardiac lesions in adults with infective endocarditis: The chaining spectrum. Am J Med 1987; 82:681.

15. Espersen F, Frimodt-Moller N. Staphylococcus aureus endocarditis. A review of 119 cases. Arch Intern Med 1986; 146:1118.

16. McMahon SW, Hickey AJ, Wlicken DEL, et al. Risk of infective endocarditis in mitral valve prolapse with and without precordial systolic murmurs. Am J Cardiol 1986; 58:105.

17. Danchin N, Voiriot P, Briancon S, et al. Mitral valve prolapso as a risk factor for infective endocarditis. Lancet 1989; 1:743-745.

18. Griffin MR, Wilson WR, Edwards WD, et al. Infective endocarditis -Olmstead County, Minesota, 1950 through 1981. JAMA 1985; 254:1199.

19. Korzeniowski OM, Kaye D. Endocarditis infecciosa. En: Tratado de Cardiología. E. Branwal (ed). IV edición. McGraw-Hill. Interamericana de España. Madrid. 1993;1207-1238.

20. Wolf M, Witchitz S. Infective Endocarditis. In: Pathophysiologic fundations of critical care. Pinsky MR et al (eds). Williams and Wilkins. Baltimore. 1993; 372-385.

21. Delahaye JP, Loire R, Milton H, et al. Infective endocarditis on stenotic aortic valves. Eur Heart J. 1988; 9(Suppl E):43-49.

22. Steckelberg JM, Melton LJ, Ilstrup DM, et al. Influence of referral bias on the apparent clinical spectrum of infective endocarditis. Am J Med 1990; 88:582.

23. Kaye Donald: Endocarditis infecciosa. In Harrison: Principios de Medicina Interna.(13ª ed). Isselbacher KJ et al (eds). Interamericana/McGraw-Hill. Madrid. 1994; 607-613.

24. Michael Pl, Acar J. Native cardiac predisposig to infective endocarditis. Eur Heart J. 1995; 16(Suppl BP):2-6.

25. Bouza E, Montero A, Tornos P, Anguita M. Profilaxis y manejo del paciente con endocarditis infecciosa. En: Normas de actuación clínica en Cardiología. Sociedad Española de Cardiología 1996: 89-98.

26. Tornos MªP, Miró JM: Endocarditis infecciosa. In Farreras - Rozman: Medicina Interna (decimotercera edción). 1995; 605-614.

27. Coykendall AL. Classification and identification of the viridans streptococci. Clin Microbiol Rev 1989; 2:315.

28. Leport C, Bure A, Leport J, Vilde JL. Incidence of colonic lesions in Streptococcus bovis and enterococcal endocarditis. Lancet 1987; 1:748.

29. Panwalker AP: Unusual infections associated with colorectal carcinoma. Rew Infect Dis 1988; 10:347.

30. Maki DG, Agger WA. Enterococcal bacteriemia: Clinical features, the risk of endocarditis and management. Medicine (Baltimore) 1988; 67:248.

31. Sanabria TJ, Alpert JS, Goldberg R, et al: Increasing frecuency of staphylococcal infective endocarditis: Experience the a University Hospital, 1981-1988. Arch Intern Med 1990; 150:1305.

32. Mylotte JM, Mac Dermott C, Spooner JA. Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteriemia. Rev Infect Dis 1987; 9:891-907.

33. Terpenning MS, Buggy BP, Kauffman CA. Hospital-adquired infective endocarditis. Arch Interm Med 1988; 148:1601-1603.

34. Fernandez-Guerrero ML, Verdejo C, Azofra J, de Górgolas M. Hospital-adquiered infectious endocarditis not associated with cardiac surgery: an emerging problem. Clin Infect Dis 1995; 20:16-23.

35. Naggar CZ, Forgacs P. Infective endocarditis: A challenging disease. Med Clin North Am 1986; 70:1279.

36. Calderwood SB, Swinski LA, Waternaux CM et al. Risk factors for the development of prosthetic valve endocarditis. Circulation 1985; 72:31.

37. Ortiz de Salazar A, Castellanos E, Aramendi JI, Llorente A, Agosti J. La endocarditis protésica. Un desafio actual en la cirugía de reeplazo valvular. Revista 0latina de Cardiología 1993; vol 14, 5:166-170.

38. Jimenez FJ, Ruiz JM, Enero J. El ecocardiograma en el postoperatorio de cirugía cardiaca. En técnicas ecocardiográficas en medicina intensiva. Editorial MCR, SA. Barcelona. 1996; pp 69-82.

39. Calderwood SB, Swinski RN, Karchwer AW, Waternaux CM, Buckley MJ. Prosthetic valve endocarditis. Analysis of factors attacting outcome of therapy. J Thorac Cardiovas Surg 1986; 92:776-783.

40. Tornos MP, Sanz E, Almirante B, Permanyer G, Planes A, Soler J. Late prosthetic valve endocarditis; inmediate and long-term pronogsis. Chest 1992; 101:37.

41. Larbalestier RI, Kinchla NM, Aranki SF, Couper GS, Collin Jr JJ, Cohn LH. Acute bacterial endocarditis. Optimizing surgical results. Circulation 1992; 86:5 (suppl II):68-74. 

42. Baddour LM. Twelve year review of recurrent native valve infective endocarditis. A disease of the modern antibiotic era. Rev Infect Dis 1988; 10:1163.

43. Gevigney G, Pop C, Dalahaye JP. The risk of infective endocarditis after cardiac surgical and intervencional procedures. Eur Heart J 1995; 16 (suppl):7-14.

44. Chastre J, Trouillet JL. Early infective endocarditis on prosthetic valves. Eur Heart J 1995; 16 (suppl):32-38.

45. Botas Rodríguez J, Alonso Martin J. Endocarditis infecciosa en pacientes adictos a drogas. Rev Esp Cardiol 1990; 43: 477-491.

46. Levine DP, Crane LR, Zervos MJ. Bacteriemia in narcotic addicts at the Detroit medical Centre. II. Infectious endocarditis: A prospective comparative study. Rev Infect Dis 1986; 8:374.

47. Chambers HF, Koerzinowski OM, Sande MA, con el National Collaborative Endocarditis study group. Staphylococcus aureus endocarditis:clinical manifestations in addicts and nonaaddicts. Medicine 1983; 62:170-177.

48. Bayer AS. Staphylococcal bacteriemia and endocarditis. Arch Intern Med 1982; 142: 1169-1177.

49. Reisberg B. Infective endocarditis in the narcotic addict. Prog Cardiovasc Dis 1979; 22:193-204.

50. Craven DE, Rixinguer A, Bisno AL, Goularte TA, Mac Cabe Wr. Bacteremia caused by group G streptococci in parenteral drug abusers: epidemiological and clinical agents: j infect Dis 1986; 153:98-99.

51. Mathew J, Addai T, Anand A, Morrobel A, Maheshwari P, Freels S. Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users. Arch Intern Med 1995; 155(15):1641-1648.

52. Torres M, Gonzalez M, Pérez E, Vergara A, Pérez J, et al. Endocarditis infecciosa en adictos a la heroina en la provincia de Cádiz. Un estudio multicéntrico de 150 casos. Med Clin (Barc). 1992; 98(14):521-526.

53. Chambers HF, Morris DL, Tauber MG, Modin G. Cocaine use and the risk for endocarditis in intravenous drug users. Ann Intern Med 1987; 106:833.

54. Cannon NJ, Coobs NG. Infective endocarditis in drug addicts. En: Kaye D, ed. Infective endocarditis. Baltimore, University Park, 1976; 111-127.

55. Chambers HF, Mills J. Endocarditis associated with intravenous drug abuse. En : Sand Ma,Kaye D, Root RK. Eds. Endocarditis. New York, Churchill Livingstone Inc, 1984; 183-201.

56. Robbins MJ, Soeiro R, Fishman WH, Strom JA. Right-sided valvular endocarditis: Etiology, diagnosis and approach to therapy. Am Heart J 1986, 111:128.

57. Eichacker PQ, Miller K, Robbins M, et al. Echocardiographic evaluation of heart valves in IV drug abusers without a previous history of endocarditis. Clin Res 1984; 32:670.

58. Rodgers GM, Greenberg CS, Shuman MA.: Characterization of the effects of cultured vascular cells on the activation of blood coagulation. Blood 1983; 61:1155.

59. Rodbard S.: Blood velocity and endocarditis. Circulation 1963; 27:18.

60. López JA, Ross RS, Fishbein MC, Siegel RJ.: Nonbacterial thrombotic endocarditis: A review. Am Heart J 1987; 113:773.

61. Ferguson DJP, McColm AA, Savage TL, et al. A morphologic study of experimental rabbit staphylococcal endocarditis and aortitis. I. Formation and effect of infected and uninfected vegetation on the aorta. Br J Exp Pathol 1986; 67:667.

62. Ferguson DJP, McColm AA, Savage TL, et al. A morphologic study of study of experimental rabbit staphylococcal endocarditis and aortitis. II. Inter-relationship of bacteria, vegetation and cardiovasculature in established infections. Br J Exp Pathol 1986; 67:679.

63. Baddour LM, Chriestensen GD, Lowrance JH, Simpson WA.: Pathogenesis of experimental endocarditis. Rev Infect Dis 1989; 11:452.

64. Everett ED, Hirschmann JV. Transiet bacteriemia and endocarditis prophilaxis. A review Medicine (Baltimore) 1997; 55:61.

65. Ragosa M, Hampp EG, Nevin TA, et al. Blood sampling and cultural studies in the detection of post-operative bacteriemia. J Am Dent Assoc 1960; 60:171.

66. Durack DT. Current issues in the prevention of infective endocarditis. Am J Med 1985; 78 (suppl B): 149.

67. Bayliss R, Clsrke C; Oakley C, Somerville W, Whitfield AGW. The teeth and infective endocarditis. Br Heart J 1983; 50:506-512.

68. Scheld WM, Valone JA, Sande MA. Bacterial adherence in the pathogenesis of endocarditis. J Clin Invest 1978; 61:1394.

69. Gould K, Ramirez-Ronda CH, Holmes RK, et al. Adherence of bacteria to heart valves in vitro. J Clin Invest. 1975; 56:1364.

70. Cheeseman SH and Carroll K: Infective endocarditis. In Rippe JM, Irwin RS, Alpert JS, Fink MP (eds): Intensive Care Medicine, 2th ed. Little Brown And Company. Boston/Toronto/London1990; 850-863.

71. Durack DT. Experimental bacterial endocarditis. IV. Structure and evolution of early lesions. J Pathol 1975; 115:81.

72. DiNubile MJ, Calderwood SB, Steinhaus DM, Karchmer AW. Cardiac conduction abnormalities complicating native valve active infective endocarditis. Am J Cardiol 1986; 58:1213. 

73. Ting W, Silverman NA, Arzouman DA, Levitzky S. Splenic septic emboli in endocarditis. Circulation 1990; 82(Suppl. IV):IV-105.

74. Mügge A, Daniel WG. Echocardiographic assement of vegetations in patients with infective endocarditis. Ecocardiography 1995; 12:651-661.

75. Gallagher PG, Watanakunakorn C. Goup B streptococcal endocarditis: Report on seven cases and review of the literature, 1962-1985. Rev Infect Dis.1986; 8:175.

76. Stein DS, Nelson KE. Endocarditis due to nutritionally deficient streptococci: Therapeutic dilemma. Rev Infect Dis 1987, 9:908.

77. Venezio FR, Gullberg RM, Westenfelder GO, et al. Group G streptococcal endocarditis and bacteremia. Am J Med. 1986; 81:29.

78. Lynn DJ, Kane JG, Parker RH. Haemophylus parainfluenzae and influenzae endocarditis. A review of forty cases. Medicine (Baltimore).1977; 56:115.

79. Woods GL, Wood RP, Shaw BW Jr. Aspergillus endocarditis in patients without prior cardiovascular surgery: Report of a case in a liver transplant recipient and review. Rev Infect Dis. 1989; 11:263.

80. Bisno AL, Dismukes WE, Durack DT, et al. Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci and stphylococci. JAMA. 1989; 261:1471.

81. Sanfilippo AJ, Picard MH, Neweld JB. Ecocardiographic assement of patients with infectious endocarditis: Prediction of risk for complications. J AM Coll Cardiol 1991; 18:1191-1199.

82. Cosmo LY, Risi G, Nelson S, et al. Fatal hemoptysis in acute bacterial endocarditis. Am Rev Respir Dis 1988; 137:1223.

83. Bayer AS, Theofilopoulos AN. Inmunopathogenic aspects of infective endocarditis. Chest 1990; 97:204.

84. Williams RC Jr, Kilpatrick K. Immunofluorescence studies of cardiac valves inionfective endocarditis. Arch Intern Med 1985; 145:297.

85. Weinstein L, Schlesinger JJ. Pathoanatomic, pathophysiologic and clinical correlations in endocarditis. N Engl J Med 1974; 291:832.

86. Scheld WM. Pathogenesis and pathophysiology of infective endocarditis. In: Sande MA, Kaye D, Root RK, (eds). Endocarditis. v. 1. Contemporary Issues in Infectious Diseases. London: Churchill Livingstone; 1984; 1-32.

87. Freedman LR. The pathogenesis of infective endocarditis. J Antimicrob Chemother. 1987; 20 (suppl A):1-16.

88. Livornese LL Jr, Korzeniowki OM. Pathogenesis of infective endocarditis. In: Kaye D, (ed). Infective Endocarditis. New York: Raven Press. 1992; 37.

89. Tunkel AR, Scheld WM. Experimental models of endocarditis. In Kaye D, (ed). Infective Endocarditis. New York: Raven Press. 1992; 37.

90. Weinstein L, Rubin RH. Infective endocarditis-1973. Prog Cardiovasc Dis. 1973; 16:239.

91. Freedman LR. Infective endocarditis and other intravascular infections. In: Braude AI, David CE, Fierer J, (eds). Medical Microbiology and Infections Diseases Philadelphia: WB Saunders. 1981; 1511.

92. Holler JW, Pecora JS. Backache in bacterial endocarditis. NY State J Med 1970; 70:1903.

93. Varma MPS, McCluskey DR, Khan MM, et al. Heart failure associated with infective endocarditis. A review of 40 cases. Br Heart J 1986; 55:191.

94. Mills J, Utley J, Abbott J. Heart failure in infective endocarditis: Predisposing factors, course and treatment. Chest 1974; 66:151.

95. Yee J, McAlliester K. The utility of Osler´s nodes in the disgnosis of infective endocarditis. Chest 1987; 92:751.

96. Watanaukunakorn C. Osler´s nodes on the dorsum of the foot. Chest 1988; 94:1088.

97. Kerr A Jr, Tan JS. Biopses of the Janeway lesion of infective endocarditis. J Cutan Pathol 1979; 6:124.

98. Salgado AV, Furlan AJ, Keys TF, et al. Neurologic complications of endocarditis: A 12 year experience. Neurology 1989; 39:173.

99. Wilson WR, Giullaini ER, Danielson GK, Geraci JE. Management of complications of infective endocarditis. Mayo Clin Proc 1982; 57:162.

100. Feinstein EI. Renal complications of bacterial endocarditis. Am J Nephrol 1985; 5:457.

101. Weinstein L. Life-threatening complications of infective endocarditis and their management. Arch Intern Med 1986;146:953.

102. Burns JMA, Hogg KJ, Hillis WS, Dunn FG. Endocarditis in intravenous drugs abusers with staphylococcal septicemia. Br Herat J 1989; 61:356.

103. Jones HR, Siekert RG. Neurological manifestations of infective endocarditis. Brain 1989; 112:1295.

104. Heimberger TS, Duma RJ. Infections of prothetics herat valves and cardiac pacemakers. Infect Dis Clin North Am 1989; 3:221.

105. Brottier E, Gin H, Brottier L, et al. Prosthetic valve endocarditis: Diagnosis and prognosis. Eur Heart J 1984; 5(Suppl C):123.

106. Werner AS, Cobbs CG, Kaye D, et al. Studies on the bacteriemia of bacterial endocarditis. JAMA 1967; 202:199.

107. Bayer AS, Lam K, Ginzton L, et al. Staphylococcus aureus bacteriemia clinical, serologic, and echocardiographic findings in patients with and without endocarditis. Arch Intern Med 1987; 147:457.

108. Ehni WF, Reller B. Short-course therapy for catheter-associated Staphylococcus aureus bacteriemia. Arch Intern Med 1989; 149:533.

109. Oakley CM. The medical treatment of culture-negative infective endocarditis. Eur Heart J 1995; 16 (suppl. ):90-93.

110. Hoen B, Selton-Suty C, Lacassin F, Etienne J, Briancon S, Leport C, Canton P. Infective endocarditis in patients with negative blood cultures: analysis of 88 cases from a one-year nationwide survey in France. Clin Infects Dis 1995; 20:501-506.

111. Hook EW. Annotation. Yale J Biol Med 1966; 38:521.

112. Whitcomb DC. Bugs in the blood: Acute staphylococcal septicemia and endocarditis diagnosed by staining the buffy coat. NC Med J. 1986; 47:293-295.

113. Tuazon CU, Sheagren JW. Teichoic acid antibodies in the diagnosis of sericous infective endocarditis with stphylococcus aureus. Ann Intern Med. 1976; 84:543.

114. Tuazon CU, Sheagren JN, Choa MS, et al. Staphylococcus aureus bacteriemia: Relationship between formation of antibodies to teichoic acid and development of metastatic abscesses. J Infect Dis 1978; 137:57.

115. Bayer AS, Theofilopoulos PN, Einsenberg R, et al. Circulating inmune complexes in infective endocarditis. N Engl J Med 1976; 295:1500.

116. Lindner JR, Alex Case R, Dent JM. Diagnostic value of echocardiography in suspected endocarditis. Circulation 1996; 93:730-736.

117. Porembka DT. Transesophageal echocardiography. Critical Care Clinics 1996; 12 (4):896-898.

118. Fisher EA, Goldman ME. Transesophageal echocardiography sound diagnostic tecnique or two-edged sword. N Engl J Med 1991; 132:841.

119. Anonymous. transesophageal echocardiography. Lancet 1992; 339:709.

120. Sochowski RA, Chan KL. Implication of negative results on a monoplane transesophageal echocardiographic study in patients with suspected infectious endocarditis. J Am Coll Cardiol 1993; 21:216.

121. Kinney EL, Wright RJ. Aortic valve vegetations: Examples of overestimation and underestimation of disease by two-dimensional echocardiography. Am Heart J 1987; 113:1248.

122. Stinson EB. Surgical treatment of active endocarditis. Prog Cardiovasc Dis 1979; 22:145.

123. Roberts NK, Somerville J. Pathologic significance of electrocardiographic changes in aortic valve endocarditis, abstrac. Br Heart J 1969; 31:395.

124. DiNubile MJ. Surgey in active endocarditis. Ann Intern Med 1982; 96:650.

125. Mills J, Abbott J, Utley JR, et al. Role of cardiac catheterization in infective endocarditis. Chest 1977; 72:576.

126. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 1994; 96:200-209.

127. Lichtma SS. Treatmentof subacute bacterial endocarditis: current results. Ann Intern Med 1943; 79:1.

128. Wolfson JS, Swartz MN: Serum bactericidal activity as a monitor of antibiotic therapy. N Engl Med 1985; 312:968. 

129. Besnier JM, Choutet P. Medical treatment of infective endocarditis: general principles. Eur Heart J. 1995 Apr. 16 Suppl BP 72-4.

130. Sande MA, Scheld WM: Combination antibiotic therapy of bacterial endocarditis. Ann Intern Med 1980; 92:390.

131. Bayer AS, Crowell D, Nast CC: Intravegetation antimicrobial distribution in aortic endocarditis analyzed by computer-generated model. Chest 1990; 97: 611.

132. Washington JA: In vitro testing of antimicrobial agents. Infect Dis Clin North Am 1989; 3:375.

133. Schlicter JG, MacIIean H. A method of determinig the effective therapeutic level in the treatment of subacute bacterial endocarditis with penicillin. Am Heart J 1947; 34:209.

134. Weisntein MP, Stratton CW, Ackley HB, Robinson PA, Fisher BC, Alcid DV, Stephens DS, Reller LB. Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective endocarditis. Am J. Med. 1985; 78:262-269.

135. Mellors JW, Coleman DL, Andriole VT. Value of the serum bactericidal test in management of patients with bacterial endocarditis. Eur. J. Clin. Microbiol. 1986; 5:67.

136. Ivers ISA, Dismukes WE, Cobbs G, et al. Prosthetic valve endocarditis. Circulation 1984; 69:223.

137. Karchmer AW, Archer GL, Dismukes WE. Staphylococcus epidermidis causing prosthetic valve endocarditis: Microbiologic and clinical observations as guides to therapy. Ann Intern Med 1983; 98:447.

138. Moellering RC. Treatment of enterococcal endocarditis. In :Sande MA, Kaye D, Root RK (eds.): Endocarditis New York. Churchill-Livingstone 1984:113-133. 

139. Threlkeld MG, Cobbs CG. Infectious Disorders of prosthetic valves and intravascular devices. In: Mandell GL, Bennet JE, Dolen R (eds.) Principles and Practice of Infectious Diseases. 4th ed. New York: 1995; 783-791.

140. Al-Kasab S, Fagih MR, Al-Yousef S, et al. Brucella infective endocarditis. Successful combined medical and surgical Therapy. J Thorac Cardiovasc Surg 1988; 95:862.

141. Levy PY, Drancourt M, Etienne J et al. Comparison of Different Antibiotic Regimens for Therapy of 32 cases of Q Fevers Endocarditis. Antimicrob Agents Chemother 1991; 35:533-537.

142. Jones RB, Priest JB, Kuo CC. Subacute chlamydial endocarditis. JAMA 1982; 247:655.

143. Thompkins LS, Roessler BJ, Redd SC, et al. Legionella prosthetic valve endocarditis. N Engl J Med 1988; 318; 530.

144. Roberts RB, Krieger AG, Schiller NL, et al. Viridans streptococcal endocarditis: The role of various species including pyridoxal-dependent streptococci. Rev Infect Dis 1979; 1:955.

145. Wilson WR, Geraci JE. Treatment of streptococcal infective endocarditis. Am J Med 1985; 78 (suppl 6B):128.

146. Handrick W, Kohler W, Spencker FB, et al. Endocarditis due to nutritionally variant streptococci. Infection 1988; 16:371.

147. Zervos MJ, Terpenning MS, Schaberg DR, et al. High-level aminoglycoside-resistant enterococci colonization of nursing home and acute care hospital patients. Arch Intern Med 1987; 147:1591.

148. Wilson WR, Wilkowske GJ, Wright AJ, et al. Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis. Am Intern Med 1984; 100:816.

149. Lipman ML, Silva J. Endocarditis due to Streptococcus faecalis with high-level resistance to gentamicin. Rev Infect Dis 1989; 11:325.

150. Eliopoulus GM, Eliopoulus CT. Therapy of enterococcal infections. Eur J Clin Microbiol Infect Dis 1990; 9:118.

151. Bisno AL, Dismukes WE, Durack DT, et al. Antimicrobial treatment of infectious endocarditis due to viridans streptococci, enterococci, and staphylococci. JAMA 1989; 261:1471.

152. Fernandez-Guerrero M, Riuse M, Henry N, et al. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus. antimicrob Agents Chemother 1988; 32:747.

153. Mullany CJ, Chua YL, Schaff HV, et al. Early and late survival after surgical treatment of culture-positive active endocarditis. Mayo Clin Proc 1995; 70:517-525.

154. Tornos PM, Alvarez A, Morillo F, et al. Timing of surgery in actuve infective endocarditis. Europ Heart J 1987; 18(supl 2).

155. Daniel WG, Mugge DE, Martin RP et al. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl Med 1991; 324:795.

156. Jaffe W, Morgan DE, Pearlman AS, Otto CM. Infective endocarditis 1983-1988: echocardiographic findings and factors influencing morbidity and mortality. J Amer Coll Cardiol 1990; 15:1227.

157. Delahaye F, Ecochard R, Gevigney G, Barjhox C, Malquarti V, Saradarian W, Delaye J. The long term prognosis of infective endocarditis. Eur Heart J 1995; 16 (suppl):48-53.

158. Kaye D. Prophylaxis against bacterial endocarditis: A dilemma. In : Kaplan EL, Taranta AV (eds): Infective Endocarditis. Dallas, American Heart Association (AHA) 1977; Monograph nº 52:67.

159. MeyerGW. Endocarditis prophylaxis and gastrointestinal procedures. Am J Gastroenterol 1989; 84 (12):1492.

160. Neu HC, Fleischer D. Recommendations for antibiotic prophylaxis before endoscopy. Am J Gastroenterol 1989; 84 (12):1489.

161. Dajani AS, Bisno AL, Chung KJ, et al. Prevention of bacterial endocarditis. JAMA 1990; 264:2919-2922.

162. Braimbridge MB, Eykyn SJ. Prosthetic valve endocarditis. J Antimicrob Chemother 1987; 20:173-180.

163. Durack DT. Prophilaxis of infective endocarditis. In: Mandell GL, Bennet JE, Dolen R (eds.) Principles and Practice of Infectious Diseases. 4th ed. New York: 1995; 793-798.

164. Simmons NA. Recommendations for endocarditis prophilaxis. J Microbiolob Chemther 1993; 31:437-453.